Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$365M |
| 2 |
Global Payments
GPN
|
+$250M |
| 3 |
NiSource
NI
|
+$109M |
| 4 |
Constellation Brands
STZ
|
+$107M |
| 5 |
Xcel Energy
XEL
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMW
VMware, Inc
VMW
|
+$95.7M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$89.4M |
| 3 |
ExxonMobil
XOM
|
+$84.7M |
| 4 |
Southern Company
SO
|
+$79.2M |
| 5 |
Emerson Electric
EMR
|
+$61.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.26% |
| 2 | Industrials | 7.84% |
| 3 | Utilities | 7.6% |
| 4 | Healthcare | 5.4% |
| 5 | Real Estate | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Viridian Therapeutics
VRDN
$2.75B
| $1.28M | 0.01% |
58,903
-115,718
| -66% | -$1.83M |
|
727
Shoals Technologies Group
SHLS
$1.19B
| $1.28M | 0.01% |
82,408
-417,592
| -84% | -$6.32M |
|
|
INN
728
Summit Hotel Properties
INN
$664M
| $1.27M | 0.01% |
189,438
+102,370
| +118% | +$630K |
|
|
FISV
729
Fiserv Inc
FISV
$28B
| $1.27M | 0.01% |
9,553
-123,250
| -93% | -$15.1M |
|
730
CALL
Netflix
NFLX
$331B
| $1.27M | 0.01% |
+26,000
| New | +$1.14M |
|
|
731
PUT
Netflix
NFLX
$331B
| $1.27M | 0.01% |
+26,000
| New | +$1.14M |
|
732
Trade Desk
TTD
$6.19B
| $1.26M | 0.01% |
+17,553
| New | +$1.29M |
|
733
Viking Therapeutics
VKTX
$3.95B
| $1.26M | 0.01% |
+67,829
| New | +$887K |
|
734
DoubleVerify
DV
$2.06B
| $1.26M | 0.01% |
+34,237
| New | +$1.07M |
|
735
Trinity Capital Inc
TRIN
$1.74B
| $1.24M | 0.01% |
+85,462
| New | +$1.23M |
|
736
Privia Health
PRVA
$2.7B
| $1.24M | 0.01% |
53,882
-173,329
| -76% | -$3.88M |
|
737
StoneX
SNEX
$8.26B
| $1.24M | 0.01% |
56,633
+4,990
| +10% | +$94.8K |
|
738
CALL
Palo Alto Networks
PANW
$292B
| $1.24M | 0.01% |
+8,400
| New | +$1.12M |
|
|
739
PUT
Palo Alto Networks
PANW
$292B
| $1.24M | 0.01% |
+8,400
| New | +$1.12M |
|
740
Chesapeake Utilities
CPK
$3.23B
| $1.24M | 0.01% |
11,695
+5,340
| +84% | +$509K |
|
741
Ameriprise Financial
AMP
$49.1B
| $1.23M | 0.01% |
3,245
-17,816
| -85% | -$6.11M |
|
742
Mine Safety
MSA
$7.31B
| $1.23M | 0.01% |
+7,302
| New | +$1.19M |
|
|
JBTM
743
JBT Marel
JBTM
$6.06B
| $1.23M | 0.01% |
12,376
+10,220
| +474% | +$1.06M |
|
744
Cars.com
CARS
$654M
| $1.21M | 0.01% |
+63,565
| New | +$1.14M |
|
745
Northwest Bancshares
NWBI
$2.26B
| $1.2M | 0.01% |
95,846
-27,722
| -22% | -$309K |
|
746
CALL
Adobe
ADBE
$109B
| $1.19M | 0.01% |
+2,000
| New | +$1.15M |
|
|
747
PUT
Adobe
ADBE
$109B
| $1.19M | 0.01% |
+2,000
| New | +$1.15M |
|
748
Valvoline
VVV
$4.33B
| $1.19M | 0.01% |
+31,705
| New | +$1.06M |
|
749
First Financial Bancorp
FFBC
$3.47B
| $1.19M | 0.01% |
50,065
+35,561
| +245% | +$737K |
|
750
Ionis Pharmaceuticals
IONS
$9.93B
| $1.19M | 0.01% |
+23,484
| New | +$1.12M |
|
Similar funds
Michael Gelband's Q4 2023 Portfolio in Review
As of Q4 2023, Michael Gelband held 2,187 positions worth $15.2B, up 46% from $10.5B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Michael Gelband deployed $3.57B of net new capital in Q4 2023, opening 553 new positions and adding to 436 existing holdings. Its largest new stake was Fidelity National Information Services: 6,650,397 shares worth $399M.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 10% a quarter earlier, followed by Industrials and Utilities.
On the sell side, the largest reduction was Merck, an estimated $48.2M trimmed.
- Michael Gelband's largest Q4 2023 buy was Fidelity National Information Services: 6,650,397 shares worth $399M.
- Michael Gelband added most to Global Payments in Q4 2023, an estimated $250M increase.
- Michael Gelband's biggest Q4 2023 reduction was Merck, cutting an estimated $48.2M.
- Michael Gelband fully exited VMware, Inc in Q4 2023, selling an estimated $95.7M.
- Michael Gelband's ten largest holdings make up 45% of its $15.2B portfolio in Q4 2023.
- Michael Gelband opened 553 new positions and closed 789 in Q4 2023.
- Michael Gelband's portfolio value rose 46% quarter-over-quarter to $15.2B.
Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.